Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (391-400 of 397) with videos related to

Pageof 40
Sort By:
You have reached the last page of results.This site can display upto 397 results.
The Lancet. Infectious Diseases|November 3, 2018
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysisJack Stone, Hannah Fraser, Aaron G Lim, et al.
Addiction (Abingdon, England)|November 22, 2023
Incarceration history is associated with HIV infection among community-recruited people who inject drugs in Europe: A propensity-score matched analysis of cross-sectional studiesAnneli Uusküla, Jürgen Rannap, Lisa Weijler, et al.
Lancet (London, England)|July 24, 2018
Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet CommissionLinda-Gail Bekker, George Alleyne, Stefan Baral, et al.
BMJ Open|September 26, 2019
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol)Matthew Hickman, John F Dillon, Lawrie Elliott, et al.
Lancet (London, England)|May 2, 2026
Implementing sustainable liver health in Europe: a second EASL-Lancet CommissionTom H Karlsen, Sharon J Hutchinson, Shira Zelber-Sagi, et al.
The Lancet. Global Health|August 9, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsJeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
The Lancet. Global Health|August 2, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsJeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
Pageof 40

Showing results (391-400 of 397) with videos related to

Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 397 results.
The Lancet. Infectious Diseases|November 3, 2018
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysisJack Stone, Hannah Fraser, Aaron G Lim, et al.
Addiction (Abingdon, England)|November 22, 2023
Incarceration history is associated with HIV infection among community-recruited people who inject drugs in Europe: A propensity-score matched analysis of cross-sectional studiesAnneli Uusküla, Jürgen Rannap, Lisa Weijler, et al.
Lancet (London, England)|July 24, 2018
Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society-Lancet CommissionLinda-Gail Bekker, George Alleyne, Stefan Baral, et al.
BMJ Open|September 26, 2019
Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol)Matthew Hickman, John F Dillon, Lawrie Elliott, et al.
Lancet (London, England)|May 2, 2026
Implementing sustainable liver health in Europe: a second EASL-Lancet CommissionTom H Karlsen, Sharon J Hutchinson, Shira Zelber-Sagi, et al.
The Lancet. Global Health|August 9, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsJeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
The Lancet. Global Health|August 2, 2014
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical modelsJeffrey W Eaton, Nicolas A Menzies, John Stover, et al.
Pageof 40